Rezultati - David Rog
- Showing 1 - 10 results of 10
-
1
Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry od Kerstin Hellwig, David Rog, Christopher McGuigan, Maria K. Houtchens, Denise R. Bruen, Oksana Mokliatchouk, Filipe Branco, Seth Levin, Nicholas Everage, Xiaochen Lin
Izdano 2024Artigo -
2
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group od Chris McGuigan, M Craner, Joseph V. Guadagno, Raj Kapoor, Gordon Mazibrada, Paul Molyneux, Richard Nicholas, Jacqueline Palace, Owen Pearson, David Rog, Carolyn Young
Izdano 2015Revisão -
3
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines od Ruth Dobson, David Rog, Caroline Ovadia, Katy Murray, Stella Hughes, Helen Ford, Owen Pearson, Sarah J. White, Nicola Bonham, Joela Mathews, Catherine Nelson‐Piercy, Peter Brex
Izdano 2022Revisão -
4
-
5
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies od Afagh Garjani, Rod Middleton, Rachael Hunter, Katherine Tuite-Dalton, Alasdair Coles, Ruth Dobson, Martin Duddy, Stella Hughes, Owen Pearson, David Rog, Emma Tallantyre, Roshan das Nair, Richard Nicholas, Nikos Evangelou
Izdano 2021Artigo -
6
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register od Nikos Evangelou, Afagh Garjani, Roshan das Nair, Rachael Hunter, Katherine Tuite-Dalton, Elaine Craig, Jeff Rodgers, Alasdair Coles, Ruth Dobson, Martin Duddy, David Ford, Stella Hughes, Owen Pearson, Linda Middleton, David Rog, Emma Tallantyre, Tim Friede, Rod Middleton, Richard Nicholas
Izdano 2020Carta -
7
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years od Jiwon Oh, Anat Achiron, Elisabeth Gulowsen Celius, Christina Chambers, Joy Derwenskus, Virginia Devonshire, Kerstin Hellwig, George J. Hutton, Pamela McCombe, Marie Moore, David Rog, Jean-Raphael Schneider, Renata Simm, Lívia Sousa, Stephen G. Vincent, Luke Chung, Nadia Daizadeh, Colin Mitchell, D. A. S. Compston
Izdano 2020Artigo -
8
Validating the portal population of the United Kingdom Multiple Sclerosis Register od Rod Middleton, Jeff Rodgers, Jeremy Chataway, Klaus Schmierer, David Rog, Ian Galea, Ashley Akbari, Katie Tuite-Dalton, Hazel Lockhart-Jones, D. J. Griffiths, David G. Noble, Kerina Jones, A. S. Najim Al-Din, Matt Craner, Nikos Evangelou, Paula Harman, Timothy Harrower, Jeremy Hobart, H. Husseyin, Marianne Kasti, Christopher Kipps, Gavin McDonnell, Charlotte Owen, Owen Pearson, Waqar Rashid, Heather Wilson, David Ford
Izdano 2018Artigo -
9
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study od J William L Brown, Nick Cunniffe, Ferrán Prados, Baris Kanber, Joanne L. Jones, Edward Needham, Zoya Georgieva, David Rog, Owen Pearson, James Overell, David MacManus, Rebecca S. Samson, Jonathan Stutters, Charles ffrench‐Constant, Claudia A. M. Gandini Wheeler‐Kingshott, Carla Moran, Paul D. Flynn, Andrew W. Michell, Robin J.M. Franklin, Siddharthan Chandran, Daniel R. Altmann, Declan Chard, Peter Connick, Alasdair Coles
Izdano 2021Artigo -
10
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised... od James Blackstone, Thomas Williams, Jennifer Nicholas, Ekaterina Bordea, Floriana De Angelis, Alessia Bianchi, Alberto Calvi, Anisha Doshi, Nevin John, Sean Apap Mangion, Charles E. Wade, Rachel Merry, Gil Barton, Dawn Lyle, Elisabeth Jarman, Don J. Mahad, Abdullah Shehu, Tarunya Arun, Gavin McDonnell, Ruth Geraldes, Matthew Craner, Charles Hillier, Jeban Ganesalingam, Leonora Fisniku, Jeremy Hobart, Cord Spilker, Neil Robertson, Seema Kalra, Stefano Pluchino, Sreedharan Harikrishnan, Miriam Mattoscio, Timothy Harrower, Carolyn Young, Martin L. Lee, Suresh Kumar Chhetri, Fayyaz Ahmed, David Rog, Eli Silber, Paul W. Gallagher, Martin Duddy, Agne Straukiene, Nicholas Richard, Claire M Rice, Stuart J Nixon, Judy Beveridge, Annie Hawton, Susan Tebbs, Marie Braisher, Gavin Giovannoni, Olga Ciccarelli, John Greenwood, Alan J. Thompson, Rachael Hunter, Sue Pavitt, Owen Pearson, Nikos Evangelou, Basil Sharrack, Ian Galea, Siddharthan Chandran, Helen Ford, Chris Frost, Jeremy Chataway
Izdano 2024Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Multiple sclerosis
Immunology
Pediatrics
Psychiatry
Biology
Cohort
Environmental health
Genetics
Obstetrics
Pathology
Population
Pregnancy
Alternative medicine
Cohort study
Coronavirus disease 2019 (COVID-19)
Disease
Expanded Disability Status Scale
Gynecology
Infectious disease (medical specialty)
Oncology
Physical therapy
Randomized controlled trial
Abortion
Adverse effect
Alemtuzumab
Bexarotene
Biochemistry
CD20